Previous studies relating increased serum levels of folate and fat-soluble vitamins to prostate cancer risk have variously shown null associations or to either decrease or increase the risk of developing prostate cancer. Prospective studies of serum folate levels have been reported to show a null association and increased serum levels to either decrease or increase the risk of subsequently developing prostate cancer. Similarly, serum b-carotene and lycopene levels have either been reported to be inversely correlated or not associated with prostate cancer risk. Using a prospective nested case-control study design, which minimized the possibility of disease effects on serum-vitamin concentrations, we report null associations for serum concentrations of folate, lycopene, b-carotene, vitamin A and vitamin E, and subsequent development of prostate cancer.
Introduction
Evidence supporting the protective effects of higher fruit and vegetable consumption on the risks of many cancers is extensive but previous studies relating serum levels of folate and fat-soluble vitamins such as b-carotene and vitamin E to prostate cancer risk have proven equivocal. Prospective studies of serum folate levels have been reported to variously show a null association (Weinstein et al., 2003) , and increased serum levels to either decrease (Rossi et al., 2006) or increase (Hultdin et al., 2005 ) the risk of subsequently developing prostate cancer. Similar ambivalent findings have been reported for b-carotene and lycopene concentrations.
Folate is necessary for DNA synthesis, repair and methylation and a low folate concentration has been implicated as a potential promoter of carcinogenesis for example, in colorectal and lung malignancies (Weinstein et al., 2003) . a possible role in prostate cancer is less certain, hence, folate concentrations were measured. The initiation and progression of prostate cancer has also been linked to oxidative stress. Dietary carotenoids are antioxidants hypothesized to be part of the host defence, potentially reducing the risk of prostate cancer (Wu et al., 2004) . b-carotene and lycopene occur mainly in orange root vegetables and tomato-based products respectively, are two of the most commonly reported carotenoids. Retinol and vitamin E were also included as diet-derived antioxidants.
The study subjects were drawn from men previously exposed to blue asbestos who were already participating in a cancer prevention trial. This was a chemoprevention programme commenced in 1990, which examined the efficacy of vitamin supplements in reducing the risk of malignant mesothelioma, lung cancer and other cancers (Musk et al., 1998) . We conducted a prospective nested case -control study of serum folate, lycopene, b-carotene, vitamin A and vitamin E concentrations and prostate cancer risk among those suffering with subsequent incident prostate cancer and randomly selected age-matched controls.
Subjects
The cohort has been described in detail by Hansen et al. (1993) and Berry et al. (2004) . At entry to the programme in 1990, all participants provided a smoking, medical and occupational histories,and height and weight were recorded. Although initially assigned to take either b-carotene (synthetic all-trans) or retinol (retinyl palmitate), preliminary analyses indicated retinol was superior with respect to reducing mesothelioma incidence, and from 1996 the men were re-assigned to take 7.5 mg of retinol/day, except those with abnormal liver function, who were supplemented with 0.4 mg of retinol/day. All participants gave their informed consent, and this study was approved by the University of Western Australia's Human Research Ethics Committee and the Clinical Drug Trials Committee of the Sir Charles Gairdner Hospital.
Serum vitamins were measured on a non-fasting sample obtained at entry to the study, before consumption of any supplements. Serum folate was analyzed by automated immunoassay (Architect i2000, Abbott, Chicago, IL, USA) and serum lycopene, b-carotene, vitamin A (retinol) and vitamin E (a-tocopherol) by high performance liquid chromatography (Thurnham et al., 1988) .
All programme participants were followed up for incident prostate cancer diagnosed after at least 1 year of enrolment in the programme until 31st December 2004, or date of death, which ever occurred first. Prostate cancer cases were histologically confirmed cases identified through record linkage with the Western Australian Cancer Registry and the Australian National Cancer Statistics Clearing House. Three controls were randomly selected for each case for the nested case-control analysis, after matching on age (within 5 years) of the case. For some cases, particularly those aged over 70 years, only two rather than three suitable controls were available for each case.
Statistical analyses
Baseline characteristics of cases and controls were compared using t-tests for continuous variables (age, body mass index and serum-vitamin concentrations) and w 2 -tests for categorical variables (smoking status). Prostate cancer risk was analyzed using conditional logistic regression models in Stata software (Intercooled Stata 9.0 for Windows. 9.0 ed. College Station, Texas, USA: StataCorp LP; 2005). Serum vitamin concentrations were analyzed as tertiles (33rd and 67th percentiles), using the 'xtile' command in Stata and on the basis of the distributions in controls. Vitamin concentrations were also analyzed as continuous variables after log transformation, because of non-normal distributions. The level for significance was set to 5% for all statistical tests. The study had 80% power to detect as significant at the 0.05 levels, a 25% increase in serum lycopene or serum folate (after log transformation) in controls compared with cases.
Results
A total of 96 cases of prostate cancer were identified during the follow-up period, and matched with 226 controls.
No differences in baseline characteristics were seen between cases and controls (Table 1) , except mean body mass index was slightly higher for cases (P ¼ 0.05). Potential confounders were selected on the basis of the original trial parameters, which were related to the risk of malignant mesothelioma and lung cancer. The following potential confounders (measured at baseline) were investigated: age, body mass index, source of asbestos exposure and smoking status (previous smoker, current smoker or never smoked). To control for randomly assigned vitamin A supplements, an intention-to-treat analysis was conducted, whereby each subject was analyzed according to the original supplement assigned to them at entry to the program. None of the potential confounders examined were statistically significant, nor did they affect the odds ratio of the main effect. However, age and vitamin A supplement were retained in all models. Table 2 shows prostate cancer risk analyzed using conditional logistic regression with serum-vitamin concentrations as tertiles. Odds ratios and 95% confidence intervals were calculated for each tertile relative to the tertile with the lowest vitamin concentration. The second tertile of lycopene levels suggested a reduction in risk, but this did not continue into the third tertile. Levels displayed a trend towards an association with protection but did not achieve significance.
Discussion
Serum b-carotene levels have either been reported to be inversely correlated with prostate cancer risk in a casecontrol study (Chang et al., 2005) or not associated in a large prospective nested case-control study (Gann et al., 1999) . Similar controversy applies to serum lycopene levels, which were reported by Chang et al. (2005) to have no association with prostate cancer risk or by Gann et al. (1999) to be inversely correlated with risk. A more recent prospective nested case-control study found a significant inverse association between serum lycopene levels only for men over 65 years without a family history of prostate cancer (Wu et al., 2004) . There is no known connection between asbestos exposure experienced in both the cases and controls and prostate cancer risk, nor can we speculate on any changes to effectiveness of the measured micronutrients in the presence of asbestos exposure. This case-control study examined several key fat-soluble vitamins, as well as plasma folate using a prospective design. The risk of subsequent development of prostate cancer was not associated with serum concentrations of folate, vitamin A, b-carotene or vitamin E. The prospective study design is an important strength, which minimized the possibility of disease or treatment effects on serum vitamin levels. Analysis of plasma vitamin levels also avoids possible difficulties with poor dietary recall when subjects complete food frequency questionnaires.
Conclusion
Our study findings are tempered by a relatively small sample size and recognition that a single sampling of serum micronutrients does not assess long term status. Risk factors specific to prostate cancer, such as prostate specific antigen levels at baseline, race and family history were not available, however we can state the subjects were predominantly of European descent.
In conclusion, we report null associations for prostate cancer and plasma folate, b carotene, vitamin concentrations similar to results reported by Weinstein et al. (2003) for folate, by Gann et al. (1999) for b-carotene and by Chang et al. (2005) for lycopene. 
